Abstract: The present invention provides a colostrum formulation enriched in broadly cross-reactive anti-endotoxin antibodies. Further provided is a method for reducing endotoxemia and blocking the onset of sepsis in patients comprising administering to the patients a colostrum formulation enriched with anti-endotoxin antibodies. Further provided is a method for treating an individual for hemolytic uremic syndrome or of protecting an individual against hemolytic uremic syndrome, comprising the step of administering to the patient an effective amount of the composition of the present invention.

Abstract: The present invention provides methods and compositions useful in the field of medicine, and particularly in the treatment of inflammatory disorders. More particularly, the invention relates to the use of methods and compositions for the treatment and prevention of disorders associated with inflammation of alimentary tract, such as human immunodeficiency virus (HIV) infection and ulcerative colitis and Crohn's disease.

Abstract: A system is provided for collecting and storing immunization and disease data. Immunization mobile stations (IMSs) are provided with a software application to facilitate the collection of patient information such as biographical data, previous vaccination data, medical history, medications in use, occupation, administration of recent vaccination, disease symptoms and the like. IMSs synchronize the patient information with information stored in a database maintained at a data center that is accessible to different groups of personnel based on different privileges defined at the data center and security measures. Patients can access electronic patient records created by the IMSs, and stored at the IMSs and/or a local server and eventually at the data center, via telephone or computer (e.g., via web browser). IMSs can capture and store images of vaccination and disease symptom sites on patients. The database allows for vaccination and disease tracking and disease control.

Abstract: A system is provided for collecting and storing immunization and disease data. Immunization mobile stations (IMSs) are provided with a software application to facilitate the collection of patient information such as biographical data, previous vaccination data, medical history, medications in use, occupation, administration of recent vaccination, disease symptoms and the like. IMSs synchronize the patient information with information stored in a database maintained at a data center that is accessible to different groups of personnel based on different privileges defined at the data center and security measures. Patients can access electronic patient records created by the IMSs, and stored at the IMSs and/or a local server and eventually at the data center, via telephone or computer (e.g., via web browser). IMSs can capture and store images of vaccination and disease symptom sites on patients. The database allows for vaccination and disease tracking and disease control.

Abstract: A transdermal delivery device includes a plurality of microneedles for injecting a substance such as a pharmaceutical agent into or below the stratum corneum of the skin. The device has housing formed from a top and bottom wall to define a chamber for containing a pharmaceutical agent. An inlet port is provided in the top wall of the housing for supplying the pharmaceutical agent to the chamber and directing the agent to the microneedles. The housing can have a Luer lock type fitting for coupling with a syringe having a Luer lock collar to inject the pharmaceutical agent into the housing. The housing can be divided into a plurality of chambers by an internal wall for supplying different agents simultaneously or sequentially to a patient. The microneedles have a length of about 5-250 microns and generally about 50-100 microns.